Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × pevonedistat × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 4 Leukemia, Myelomonocytic, Chronic 2 Thrombocytosis 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Leukemia, Prolymphocytic, B-Cell 1 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hypereosinophilic Syndrome 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 31 Doxorubicin 20 pembrolizumab 19 fludarabine 18 Nivolumab 18 fludarabine phosphate 16 Vinblastine 16 Dacarbazine 16 Brentuximab Vedotin 16 Whole-Body Irradiation 15 Mycophenolic Acid 15 Etoposide 13 Melphalan 12 Filgrastim 11 Tacrolimus 10 Gemcitabine 10 Bleomycin 9 Rituximab 8 Radiotherapy 8 Granulocyte Colony-Stimulating Factor 8 Vincristine 7 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 pegfilgrastim 6 Stem Cell Transplantation 6 Magnetic Resonance Spectroscopy 6 Bendamustine Hydrochloride 6 Thiotepa 5 Specimen Handling 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡